ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burgess, C
Right arrow Articles by Beasley, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burgess, C
Right arrow Articles by Beasley, R
Eur Respir J 1994; 7: 498-503
Copyright © ERS Journals Ltd 1994


Original Articles

Prescribed drug therapy and near-fatal asthma attacks

C Burgess, N Pearce, R Thiruchelvam, R Wilkinson, C Linaker, K Woodman, J Crane, and R Beasley

Inhaled fenoterol has been associated with an increased risk of death in severe asthmatics, when compared to other adrenoceptor agonists. It is plausible that fenoterol may also increase the risk of near-fatal attacks. We have conducted a case-control study to investigate this hypothesis. The cases comprised Intensive Care Unit (ICU) admissions for asthma in the Wellington region during 1977-1988. For each of these cases, two age-matched controls were selected from asthma admissions to the same hospital during the same period. For the 155 cases and 305 controls, information on prescribed drug therapy was collected from the hospital admission records. The relative risk of a near-fatal asthma attack in patients prescribed inhaled fenoterol was 2.00 (95% confidence interval (CI) 1.35-2.97). An increased risk was also observed for oral theophylline (odds ratio (OR) = 1.88; 95% CI 1.26-2.79). For the 65 cases and 104 controls who had a previous admission for asthma in the previous 12 months, information relating to the previous admission was also collected; an increased risk was once again observed for inhaled fenoterol (OR = 2.18; 95% CI 1.10-4.33) and for oral theophylline (OR = 1.18; 95% CI 0.99-3.57). No other asthma drugs showed significantly increased risks. Although the ICU admission cases had generally been prescribed more asthma drugs than the hospital admission controls, and appeared to have more severe asthma, it is possible that the findings reported here are influenced by confounding by severity. We nevertheless estimate that our findings are consistent with the hypothesis that fenoterol increases the risk of near-fatal asthma attacks, and that they complement previous findings on fatal asthma attacks.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Eur Respir JHome page
D.J. Eckert, P.G. Catcheside, and R.D. McEvoy
Blunted sensation of dyspnoea and near fatal asthma
Eur. Respir. J., August 1, 2004; 24(2): 197 - 199.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M.D. Eisner, T.A. Lieu, F. Chi, A.M. Capra, G.R. Mendoza, J.V. Selby, and P.D. Blanc
Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma
Eur. Respir. J., February 1, 2001; 17(2): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Kolbe, W Fergusson, M Vamos, and J Garrett
Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack
Thorax, December 1, 2000; 55(12): 1007 - 1015.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. O. TURNER, K. NOERTJOJO, S. VEDAL, T. BAI, S. CRUMP, and J. MARK FITZGERALD
Risk Factors for Near-fatal Asthma . A Case-Control Study in Hospitalized Patients with Asthma
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1804 - 1809.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.